75% off non-attaching, single-donor human hepatocytes for short incubation metabolism studies (view details)

New High AO/XO Test Systems

New method for high aldehyde oxidase and xanthine oxidase activity in pooled human liver S9 and cytosol


cryostax-vials.jpgSekisui XenoTech offers unrivaled quality and selection with an extensive array of products to assist all your in vitro ADME research needs. Our standard products feature cellular and subcellular fractions, hepatocytestissue samples, media and more from many different toxicologically relevant species. We are the sole North American distributor for cell lines from JCRB, recombinant CYP enzymes, P450 substrates and metabolites from Cypex, and metabolite production kits from HepatoChem. Whatever your in vitro research needs, Sekisui XenoTech can help. Order all your products online in our eStore!

Start shopping now!


At Sekisui XenoTech, we recognize the importance of having readily available, reliable information. Our customers rely both on the quality of our products and on our expertise in biotransformation to help them with their research needs.

Visit our scientific resource center

Sekisui XenoTech's scientific resources as well as cell and tissue-based products stem from our unparalleled global contract research experience and proven expertise from discovery through clinical support.

Explore our contract research services

News and Events

  • Sunday, March 11, 2018

    SOT 2018

    Sekisui XenoTech will be at the SOT Annual Meeting & ToxExpo booth #441 on Mar. 11-15, 2018.

  • Wednesday, October 18, 2017

    Sekisui XenoTech Appoints New COO

    Sekisui XenoTech has announced the appointment of Dr. Darren Warren, PhD, as the company’s new Chief Operating Officer. Dr. Warren has over 15 years of leadership experience with Contract Research Organizations (CROs) and almost 30 years of leadership experience in the pharmaceutical industry...

  • Monday, August 14, 2017

    New Enhanced AO & XO Activity Test Systems Available, Major CYP Activity Not Significantly Impacted

    Sekisui XenoTech has established a method for high aldehyde oxidase and xanthine oxidase activity without significantly impacting major CYP activity in pooled human liver S9 and cytosol in vitro drug development test systems…